Ivana was Chief Executive Officer and President at Vigil Neuroscience, and Director at Acrivon Therapeutics. Ivana Magovčević-Liebisch joined Acrivon Therapeutics in 2024.
Ivana Magovčević-Liebisch is currently
Create your alert
to follow the career of Ivana Magovčević-Liebisch.
Ivana Magovčević-Liebisch has a Juris Doctor in High Technology Law from Suffolk University and a PhD in Genetics from Harvard University.
They have also studied at Suffolk University :
Find more alumni from Suffolk University
They have also studied at Harvard University :
Find more alumni from Harvard University
Do you need to know more about Ivana Magovčević-Liebisch? More results.
Report an error
Update the org chart details of Ivana Magovčević-Liebisch.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.